Science Explorer Interactive view Map
Company · Cambridge · United States

Rubius Therapeutics (United States)

rubiustx.comROR OpenAlex
Research works
27
▲ 370% vs 2013–17
Citations
513
18.8 per fractional work
Top-10% rate
4.2%
record average 16.5%
Open access
32%
world 28%

Not ranked overall: Rubius Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Rubius Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Gene Therapy and Antigen Presentation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Cancer Immunotherapy7▲ 194×3 topics
  2. Immunotherapy7▲ 38×4 topics
  3. Tumor Regression6▲ 265×2 topics
  4. Lymphoma4▲ 109×2 topics
  5. CAR T Cells4▲ 363×1 topic
  6. Chimeric Antigen Receptor4▲ 363×1 topic
  7. Gene Therapy4▲ 51×3 topics
  8. Antigen Presentation4▲ 132×2 topics
  9. Dendritic Cells3▲ 89×1 topic
  10. Immunity3▲ 30×1 topic
  11. Tumor Targeting2▲ 65×2 topics
  12. Arginine Deprivation2▲ 167×1 topic
  13. Bacterial Therapy2▲ 167×1 topic
  14. Cancer2▲ 5.0×5 topics
  15. Glycosylation2▲ 32×3 topics
  16. Transcriptional Regulation2▲ 26×5 topics
  17. NK Cell Recognition2▲ 60×1 topic
  18. Natural Killer Cells2▲ 60×1 topic
  19. AAV1▲ 77×1 topic
  20. Viral Vectors1▲ 77×1 topic
  21. Immune System1▲ 12×2 topics
  22. Inflammation1▲ 1.78×8 topics
  23. Therapeutics1▲ 29×2 topics
  24. Glycans1▲ 46×1 topic
  25. Insulin Resistance1▲ 8.1×3 topics
  26. Metabolic Syndrome1▲ 4.3×3 topics
  27. Mucins1▲ 46×1 topic
  28. Obesity1▲ 4.9×4 topics

Which research topics does Rubius Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Cardiovascular Function and Risk Factors, Mitochondrial Function and Pathology and Monoclonal and Polyclonal Antibodies Research.

CAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksCardiovascular Function …0Cardiovascular Function and Risk Factors: 0 fractional worksMitochondrial Function and Pathology: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksMetabolism, Diabetes, and Cancer: 0 fractional worksDiabetes Treatment and Management: 0 fractional worksPeroxisome Proliferator-…0Peroxisome Proliferator-Activated Receptors: 0 fractional worksBiochemical Acid Research Studies: 0 fractional worksSarcoma Diagnosis and Treatment: 0 fractional works
OncologyCardiology and Cardiovascular MedicineMolecular BiologyRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 0 works
  2. 2 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
  3. 3 Mitochondrial Function and Pathology Molecular Biology 0 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 vaccines and immunoinformatics approaches Molecular Biology 0 works
  6. 6 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
  7. 7 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Peroxisome Proliferator-Activated Receptors Molecular Biology 0 works
  9. 9 Biochemical Acid Research Studies Biochemistry 0 works
  10. 10 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.4%not open67.6%

World: 28% of research is openly available.

with international co-authors17.0%domestic only83.0%

World: 19% is written across borders.

How has Rubius Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 370% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.